Escitalopram + Placebo

DRUG2 trials

Sponsors

University of Pennsylvania, Laureate Institute for Brain Research, Inc.

Conditions

DepressionInflammation

Phase 2

Adherence to Antidepressant Treatment in Subjects With Depression

TerminatedNCT03388164

Laureate Institute for Brain Research, Inc.Depression

Start: 2018-01-01End: 2019-05-15Updated: 2021-09-16

Phase 4

Stress and Inflammation in Late-Life Depression

CompletedNCT02389465

University of PennsylvaniaDepression, Inflammation

Start: 2014-08-31End: 2022-07-18Updated: 2023-10-02

Related Papers

Methylphenidate augmentation of escitalopram to enhance adherence to antidepressant treatment: a pilot randomized controlled trial.

2021-11-19